Additional research in rat models suggests that semaglutide has neuroprotective properties in the treatment of Parkinson's disease, attributed to its prevention of neuronal apoptosis and anti-inflammatory effects [20]
It frames that monitoring as the core of safe use, alongside prompt reporting of persistent vomiting, severe abdominal pain, or unexplained hypoglycemia to the prescribing clinician
10.1200/PO.21.00505 142 ReelP
Because retatrutide is not yet licensed for clinical use in the UK, these timelines are drawn from trial data rather than real-world clinical experience
With the drugs' novelty and soaring popularity, it's important for consumers to know about the effects on all organ systems and become aware of the need for careful monitoring, researchers noted
Phase II liver detox bottleneck impaired sulfation and conjugation